Table 2.
Dose distribution for ten most frequently used antipsychotics during stable-dose period among case and control cohorts
| Drug | Case (N, %) | Case Stable Dose (mg), Mean ± SD | Control (N, %) | Control Stable Dose (mg), Mean ± SD |
|---|---|---|---|---|
| Risperidone | 4564 (23.3) | 7 ± 7 | 4135 (21.1) | 5 ± 6 |
| Quetiapine | 3871 (19.8) | 463 ± 278 | 3226 (16.5) | 331 ± 254 |
| Olanzapine | 2558 (13.1) | 22 ± 13 | 2422 (12.4) | 17 ± 12 |
| Aripiprazole | 1838 (9.4) | 29 ± 47 | 2712 (13.9) | 22 ± 38 |
| Paliperidone | 1180 (6.0) | 70 ± 68 | 1704 (8.7) | 56 ± 63 |
| Haloperidol | 1472 (7.5) | 31 ± 30 | 1396 (7.1) | 22 ± 19 |
| Ziprasidone | 1185 (6.1) | 147 ± 61 | 1026 (5.2) | 125 ± 55 |
| Clozapine | 1251 (6.4) | 407 ± 180 | 683 (3.5) | 405 ± 190 |
| Lurasidone | 467 (2.4) | 93 ± 42 | 820 (4.2) | 68 ± 35 |
| Fluphenazine | 301 (1.5) | 20 ± 13 | 277 (1.4) | 15 ± 11 |
SD standard deviation